Mobile: 9207461932
Email: info@scire.co.in
Website: www.scire.co.in
Scire Science is a pioneering medtech and biotech company dedicated to transforming healthcare research and innovation . At the forefront of regenerative medicine, we specialize in 3D bioprinting and biomaterials solutions, proudly manufacturing India’s first indigenous bioink. Our commitment to research, development, and product excellence enables us to deliver cutting-edge solutions that advance personalized medicine and regenerative therapies.
Our 3D bioprinting division leads in developing custom bioprinting solutions, enabling the creation of complex tissues and organ models for research and clinical applications.
Additionally, our cell culture services provide high-quality cell lines and customized culture solutions, addressing the evolving needs of the scientific community.
Beyond research and innovation, Scire Science is committed to education and professional development in biotech and medtech. We offer specialized training programs in bioprinting, cell culture, and project management, along with placement assistance to support career growth.
At Scire Science, we are shaping the future of healthcare, research, and education, pushing the boundaries of what’s possible in biotechnology and regenerative medicine.
Main area of product. Biomaterials and Bioinks
Founded in 2016, Scire Science Pvt Ltd embarked on a mission to advance science and technology through research, innovation, and education. Initially focused on industry- academia collaboration, the company steadily expanded its scope, engaging in contract research, specialized training, and product development through strategic MoUs with institutions and collaborative projects. Over the years, Scire Science has built a strong customer base, reinforcing its commitment to knowledge dissemination and scientific progress.
In 2020, the company diversified into the hygiene and skincare sector, leveraging a drug license to enhance its product offerings. Simultaneously, Scire Science established a state-of- the-art facility for cell-based studies, emphasizing 3D cell culture and bioprinting technologies to push the boundaries of regenerative medicine. One of its standout innovations, Thermabead, a compact bead bath for thawing reagents, has significantly improved contamination-free lab processes.
Upon realization of an ambitious vision—bringing an indigenous 3D bioprinting revolution to India, In 2024 Scire Science has launched India’s first indigenous Bioink, Scire Chitra GelMA UVS Bioink, a breakthrough developed using the technological expertise of Sree Chitra Tirunal Institute, Trivandrum. This milestone underscores the company’s pioneering role in indigenous Bioink manufacturing. With gratitude for the unwavering support from partners, researchers, and the scientific community, Scire Science remains committed to shaping the future of bioprinting, regenerative medicine, and cutting-edge scientific advancements in India and beyond.
Director & Chief Technology Officer:
Dr Jikku Jose
Scire ThermaBead – BB70
.png)